Syrma SGS Technology delivered a blockbuster performance in the quarter ended March 31, 2026. The electronics manufacturing services (EMS) player reported consolidated revenue of ₹1,477 crore, a staggering 56% jump year-on-year. Net profit surged 67% to ₹119 crore, while EBITDA climbed 43% to ₹186 crore. For the full fiscal year FY26, revenue grew 27% to ₹4,857 crore, and profit after tax nearly doubled, jumping 87% to ₹346 crore.
This exceptional performance didn't just impress analysts—it sent the stock on a wild ride. Shares hit a fresh all-time intraday high of ₹1,187.10 on May 12, 2026, capping a remarkable 98.5% return over the past year. However, the euphoria was short-lived. After touching the peak, the stock reversed course to close at ₹1,075.20, down 3.36% on the day. This volatility tells a story of strong fundamentals meeting market caution.
The revenue surge wasn't a fluke—it was broad-based. All five of the company's industry segments contributed, but two stood out. The IT and Railways segment exploded, growing 182% year-on-year to ₹140 crore. The Consumer segment also delivered triple-digit growth, rising 102% to ₹383 crore. The Industrials and Auto segments grew 21% and 62% respectively, while Healthcare added 47%. InvestorPresentations
Exports played a massive role. Export revenue grew 41% year-on-year to reach ₹1,200 crore for FY26, comfortably exceeding the company's own guidance of ₹1,100 crore. This constituted 25% of total operating revenue. Management highlighted that they are "by far the largest exporter of electronics outside the mobile space," a significant competitive moat in the China Plus One era. InvestorPresentations
Strategic moves made earlier began paying off. The consolidation of Elcome in the defense electronics segment and the Elemaster joint venture in high-reliability industrial and railways electronics started contributing meaningfully. These acquisitions aren't just about adding revenue—they're about moving up the value chain into higher-margin, specialized verticals.
Profit growth outpaced revenue growth, indicating operational leverage. EBITDA margins for the full year expanded 230 basis points to 12.0%, while PAT margins improved 230 basis points to 7.1%. This margin expansion was driven by better operational efficiency and improved cost management. InvestorPresentations
The company kept a tight rein on expenses. Operating expenses grew at a slower pace (42.8% year-on-year) compared to revenue growth (56%), showing improved cost efficiency. Finance costs actually decreased 17.4% year-on-year in FY26, reflecting improved debt management. Working capital days improved from 69 days in FY25 to 63 days in FY26, freeing up cash flow. InvestorPresentations +2
Return metrics improved significantly.
Adjusted ROCE, including goodwill, reached 20.1%. These numbers suggest the company is becoming more efficient at deploying capital, a crucial factor for sustaining growth. InvestorPresentations
The stock's journey to its record high was fueled by momentum. Before the results were even announced, the stock had already gained 6.5% over two consecutive days (May 7-8, 2026), hitting ₹1,135.70. This pre-results rally suggested the market was anticipating strong numbers and positioning accordingly.
When the results dropped, they exceeded even these elevated expectations. The stock gapped up to hit ₹1,187.10 on May 12, 2026. Technical indicators were bullish—the stock was trading above all key moving averages, and delivery volumes showed strong institutional interest. The company had also just received a credit rating upgrade from India Ratings & Research to IND AA/Stable, adding to the positive sentiment.
So why the decline? Several factors were at play. First, profit booking. After a 139% annual rally, many investors decided to take money off the table despite the strong results. Second, broader market weakness—the Nifty 50 declined 0.87% on results day, creating headwinds. Third, valuation concerns.
The PEG ratio of 0.9 suggests earnings growth has kept pace with price gains, but investors remain cautious about sustainability at these levels.
The volatility indicates a market that believes in the long-term story but is nervous about near-term valuation. The 6.5% pre-results jump was anticipatory, validated by the 67% profit growth. However, the post-results decline shows investors are now focused on whether this growth is sustainable and whether the current price already discounts too much of the future.
Management has laid out an ambitious roadmap for FY27. The company expects around 30% growth across all parameters—revenue, EBITDA, and profit before tax. This would take total revenue to approximately ₹6,300-6,400 crore. EBITDA is targeted at ₹650 crore, with margins guided at 10-10.5% for the year, though management sees room for improvement to 10-11% if global supply chain conditions stabilize. Transcripts +1
Exports are a key pillar of this growth. The company expects exports to cross ₹1,500 crore in FY27, up from ₹1,200 crore in FY26. This represents 25%+ growth. Key geographic markets include the United States (approximately ₹255 crore in 9M FY26) and European markets like Belgium and Germany (approximately ₹580 crore). The company has a physical factory and engineering presence in Stuttgart, Germany, giving it a strategic foothold in the European market. Transcripts
Several strategic initiatives support this growth trajectory. The PCB manufacturing plant is under construction, with completion expected by June-July 2026 and trial production scheduled to start by December 2026. The Bangalore facility expansion is also on track. The Elcome acquisition is expected to contribute ₹280-300 crore in FY26 with 10-15% growth potential in FY27. The Elemaster JV provides a platform for high-reliability industrial and railway electronics. Transcripts +2
The path to 30% growth isn't without obstacles.
Commodity prices are in a state of flux, and supply chain disruptions from the Middle East are creating volatility. This is why the company is guiding for conservative EBITDA margins of 10-10.5% for FY27.
Integration risks from rapid expansion are real. The company has completed multiple acquisitions (Johari Digital, SGS Tekniks, Elcome) within a three-year window. Administrative and general expenses are up 35% year-on-year due to synchronization efforts. With 13 manufacturing locations, there's a risk of operational silos and inconsistent quality control.
Competition is intense. The company faces pressure from global EMS giants like Foxconn and Wistron, as well as domestic players like Dixon Technologies, which reported 100%+ growth in select segments. These competitors benefit from larger economies of scale and lower cost of capital. Margin pressure remains a persistent threat in the EMS industry, where net margins for peers often hover in the 2-6% range.
Working capital management is another area to watch. Working capital stands at approximately 25% of revenue, and inventory days are around 95 days. Debtors turnover declined to 2.05 times in H1 FY26, suggesting slower collection cycles. While the company has improved net working capital days from 69 to 63, further improvement is needed to support rapid growth without straining liquidity.
How does Syrma SGS stack up against its peers? In Q4FY26, it outperformed Kaynes Technology India on growth metrics (56% vs 54% revenue growth; 67% vs 43% PAT growth), though Kaynes maintains better margins (15% vs 12.6% EBITDA).
Syrma SGS's competitive advantages are clear. It's the largest exporter of electronics outside the mobile space, giving it a strong position in the China Plus One narrative. Its diversified segment presence across Auto, Industrial, Healthcare, Defense, and IT & Railways reduces dependency on any single vertical. Strategic acquisitions in defense (Elcome) and high-reliability industrial electronics (Elemaster JV) are moving it into specialized, higher-margin niches. Sustainability credentials like the EcoVadis Gold rating and the recent credit rating upgrade to IND AA/Stable add to its appeal for global OEMs.
The strong Q4FY26 results have significantly enhanced Syrma SGS's positioning within the broader semiconductor/EMS sector. It's now viewed as a high-growth, export-oriented leader with improving operational efficiency. Institutional confidence is growing—Mutual Fund holding stands at 9.74% and FII holding at 6.60%, both increased from the previous quarter. Analyst sentiment is overwhelmingly positive, with 18 out of 24 analysts rating it a Strong Buy or Buy.
Syrma SGS Technology has delivered a masterclass in execution. The 56% revenue jump and 67% profit surge in Q4FY26 are testament to a strategy that's working—diversified segments, export-led growth, and strategic acquisitions. The stock's volatility reflects the market's struggle to balance this strong performance against rich valuations and global uncertainties.
Looking ahead to FY27, the 30% growth target is ambitious but backed by tangible drivers. The PCB plant, Bangalore facility expansion, Elcome integration, and Elemaster JV provide multiple growth engines. The export push into US and European markets leverages the China Plus One trend. However, execution risks loom large—integration challenges, competitive pressure, and working capital management will be critical to watch.
For investors, the story is compelling but not without risk. The company has proven it can grow fast and improve margins. The question now is whether it can sustain this pace without breaking. The FY27 guidance suggests management believes it can. The market, judging by the post-results volatility, remains to be fully convinced. As always, the proof will be in the execution.
